SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Indonesia Energy Corp. Ltd. operates as an oil and gas, exploration, and production company. It engages in oil and gas assets portfolio with a mix between medium-sized producing blocks and exploration blocks with significant resources. Its portfolio includes Kruh, Citarum, and Rangkas Area. The company was founded by James J. Huang and Wirawan Jusuf in 2014 and is headquartered in Jakarta, Indonesia.

Indonesia Energy Corp Ltd

Escalating geopolitical tensions in the Middle East, including drone strikes on a major Saudi oil refinery and fears of a Strait of Hormuz disruption, are driving conversation around Indonesia Energy Corp. The community highlights the stock's low float and potential for a short squeeze, recalling its significant moves during prior global energy market volatility.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray Brands is trending following a trading halt prompted by its acquisition of key BrewDog assets and a new U.S. licensing deal with Carlsberg, igniting investor debate. While some hail these beverage sector moves as strategic expansion ahead of potential cannabis rescheduling, many criticize management's past acquisitions and express concern over potential dilution.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas is trending following its $10 million strategic investment and partnership with World View to develop multi-domain intelligence, surveillance, and reconnaissance solutions for defense. The community is actively discussing how this positions the company to benefit from escalating global demand for drone and counter-drone technologies, amplified by high short interest fueling squeeze speculation.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is trending as heightened global geopolitical tensions put drone warfare in the spotlight, fueling community speculation about increased demand for its defense solutions and anticipation of critical "Drone Dominance" program results.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending due to NVIDIA's increasing focus on photonics for AI data centers, amplifying discussions around POET's disruptive optical interconnect technology. The community is actively debating its potential for significant hyperscaler partnerships and a strong revenue ramp, with many anticipating pivotal announcements leading up to the OFC conference.

Exxon Mobil Corp. engages in the exploration, development, and distribution of oil, gas, and petroleum products. It operates through the following segments: Upstream, Energy Products, Chemical Products, and Specialty Products. The Upstream segment organizes the exploration of crude oil and natural gas. The Energy Products segment includes fuels, aromatics, and catalyst and licensing. The Chemical Products segment offers petrochemicals. The Specialty Products segment provides finished lubricants, basestocks and waxes, synthetics, and elastomers and resins. The company was founded by John D. Rockefeller in 1882 and is headquartered in Spring, TX.

Exxon Mobil Corp.

Exxon Mobil Corp

Exxon Mobil is a top trending stock as escalating Middle East tensions, including reported closures of the Strait of Hormuz and attacks on major oil and LNG facilities, ignite fervent community discussion. Traders are sharply divided on whether these supply disruptions will lead to a sustained energy price rally, significantly benefiting XOM, or if the initial surge will quickly fade.

Venture Global, Inc. engages in the development and construction of liquefied natural gas production, establishing us as a rapidly growing company delivering critical LNG to the world. It projects include Calcasieu, Plaquemines, CP2, CP3 and Delta projects. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is trending amid strong earnings driven by surging LNG volumes and strategic contract signings, fueling community discussion around its significant spot market exposure and growth potential. The broader LNG sector, including Venture Global, is also in focus as rising global natural gas prices and heightened geopolitical tensions in key shipping routes underscore the critical demand for diversified energy supply.

Nokia Oyj engages in the provision of network infrastructure, technology, and software services. It operates through the following segments: Mobile Networks, Network Infrastructure, Cloud and Network Services, and Nokia Technologies. The Mobile Networks segment offers technologies for Radio Access Networks (RAN) as well as Microwave Radio Links (MWR) for transport networks. The Network Infrastructure serves communication service providers, enterprises, webscales and public sector customers. The Cloud and Network Services segment builds around software and the cloud and is focused on driving leadership in cloud-native software and as-a-service delivery models, as demand for critical networks accelerates; and with strong market positions in communications software, private wireless networks, and cognitive (or intelligent) services. The Nokia Technologies segment, building on decades of innovation and R&D leadership in technologies used in virtually all mobile devices used today, is expanding the Nokia patent licensing business, reintroducing the Nokia brand to smartphones through brand licensing, and establishing a technology licensing business. The company was founded by Fredrik Idestam in 1865 and is headquartered in Espoo, Finland.

Nokia Corp - ADR

Nokia Corp

Nokia is gaining significant attention as investors highlight its strategic partnership and investment from NVIDIA, positioning the company as a foundational architect for AI-ready 5G and 6G networks. The community is actively discussing Nokia's crucial role in the burgeoning AI supercycle, viewing it as a reawakened telecom infrastructure powerhouse.

AeroVironment, Inc. engages in the design, development, and production of multi-domain robotic systems and related services for government agencies and businesses. It operates through the following business segments: UnCrewed Systems, Loitering Munitions Systems, and MacCready Work. The UnCrewed Systems segment focuses primarily on small UAS products designed to operate reliably at lower altitudes in a wide range of environmental conditions. The Loitering Munitions Systems segment focuses primarily on tube-launched aircraft that deploy with the push of a button, fly at higher speeds than small UAS products, and perform either effects delivery or reconnaissance missions, and related support services including training, spare parts, product repair, and product replacement. The MacCready Works segment focuses on customer-funded research and development in the areas of HAPS, robotics, sensors, software analytics, data intelligence, and connectivity. The company was founded by Paul B. MacCready, Jr. in July 1971 and is headquartered in Arlington, VA.

AeroVironment Inc.

AeroVironment is trending amid significant volatility, recently impacted by an earnings miss and a government contract renegotiation, which some in the community view as an overreaction. Nevertheless, sustained discussions highlight AVAV as a crucial drone technology leader, positioned to benefit from escalating global defense spending and bolstered by recent positive analyst coverage.

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is trending as the FDA lifted the clinical hold on its MAGNITUDE-2 Phase 3 trial, sparking hopes for a significant short squeeze given its high short interest. The community is actively discussing the stock's potential to rebound to previous levels, while also awaiting updates on the larger ATTR-CM trial.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Erste Asset Management GmbH Takes $1 Million Position in Nektar Therapeutics $NKTR

Erste Asset Management GmbH purchased a new stake in Nektar Therapeutics (NASDAQ:NKTR - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the...

Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2025 on Thursday, March 12, 2026, After Close of U.S.-Based Financial Markets

Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2025 on Thursday, March 12, 2026, After Close of U.S.-Based Financial Markets Nektar to Announce Financial Results for the...

Wall Street Analysts Think Nektar (NKTR) Could Surge 89.8%: Read This Before Placing a Bet

The mean of analysts' price targets for Nektar (NKTR) points to an 89.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Nektar Therapeutics to Participate in Two Investor Conferences in March

Nektar Therapeutics to Participate in Two Investor Conferences in March Nektar Therapeutics to Participate in Two Investor Conferences in March PR Newswire SAN FRANCISCO, Feb. 24, 2026 SAN FRANCISCO...

Nektar Therapeutics (NASDAQ:NKTR) Sets New 52-Week High - Time to Buy?

Nektar Therapeutics (NASDAQ:NKTR) Sets New 1-Year High - Should You Buy...

Nektar Therapeutics (NASDAQ:NKTR) Given Buy Rating at B. Riley Financial

B. Riley Financial reiterated a "buy" rating and issued a $150.00 price target (up from $105.00) on shares of Nektar Therapeutics in a research report on Monday...

Nektar Therapeutics (NASDAQ:NKTR) Insider Sells $13,140.00 in Stock

Nektar Therapeutics (NASDAQ:NKTR - Get Free Report) insider Jonathan Zalevsky sold 180 shares of the stock in a transaction on Wednesday, February 18th. The shares were sold at an average price of...

Jonathan Zalevsky Sells 180 Shares of Nektar Therapeutics (NASDAQ:NKTR) Stock

Nektar Therapeutics (NASDAQ:NKTR - Get Free Report) insider Jonathan Zalevsky sold 180 shares of the firm's stock in a transaction that occurred on Wednesday, February 18th. The shares were sold at...

Howard Robin Sells 423 Shares of Nektar Therapeutics (NASDAQ:NKTR) Stock

Nektar Therapeutics (NASDAQ:NKTR - Get Free Report) CEO Howard Robin sold 423 shares of the company's stock in a transaction dated Wednesday, February 18th. The stock was sold at an average price of...

Persistent Asset Partners Ltd Takes $983,000 Position in Nektar Therapeutics $NKTR

Persistent Asset Partners Ltd purchased a new stake in Nektar Therapeutics (NASDAQ:NKTR - Free Report) during the 3rd quarter, according to the company in its most recent filing with the Securities...

Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit. The company was founded in 1990 and is headquartered in San Francisco, CA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$2.47	--	--	N/A
Q3 '25	-$2.68	-$1.87	30.35%	BEAT
Q2 '25	-$3.03	-$2.95	2.56%	BEAT
Q1 '25	-$0.17	-$3.60	-2005.88%	MISSED
Q4 '24	-$0.14	$0.03	122.12%	BEAT

NKTR
Nektar Therapeutics

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest NKTR News

NKTRNektar Therapeutics